The Berberine Derivative BBR684 Inhibits VDAC Oligomerization to Suppress Ferroptosis in Acute Kidney Injury

Authors

Institutions

Publication Details

Journal
Current Therapeutic Research
Published
2026-02-13
DOI
https://doi.org/10.1016/j.curtheres.2026.100825
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Berberine Derivative BBR684 Inhibits VDAC Oligomerization to Suppress Ferroptosis in Acute Kidney Injury

Yongjian Guo, Zihao Jiang, Guo Chen, Wenhao Zhang et al.
Current Therapeutic Research
Ferroptosis and cancer prognosis
article

The Berberine Derivative BBR684 Inhibits VDAC Oligomerization to Suppress Ferroptosis in Acute Kidney Injury

Yongjian Guo, Zihao Jiang, Guo Chen, Wenhao Zhang, Cong Wang, Jiawei Zhu
article en

Abstract

No abstract available for this paper.
Current Therapeutic ResearchVol. 104
Qingdao University (CN), China Pharmaceutical University (CN), Jiangsu Vocational Institute of Commerce (CN), Affiliated Hospital of Qingdao University (CN), Qingdao Municipal Hospital (CN), First People's Hospital of Chongqing (CN), Chongqing Dazu District People's Hospital (CN), Chongqing Medical University (CN)
Good health and well-being
Openalex Percentile: Top 56%
Ferroptosis and cancer prognosis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.